AS type | Â | Significant pairs | with homologous genes and enhancers | Percentage | Â | Insignificant pairs | with homologous genes and enhancers | Percentage |
---|---|---|---|---|---|---|---|---|
A5SS | Â | 1046 | 553 | 52.87% | Â | 266,860 | 97,639 | 36.59% |
A3SS | Â | 2129 | 1122 | 52.70% | Â | 436,986 | 160,042 | 36.62% |
SE | Â | 3070 | 1631 | 53.13% | Â | 731,628 | 256,762 | 35.09% |
RI | Â | 5792 | 3115 | 53.78% | Â | 894,218 | 319,572 | 35.74% |
MSE | Â | 6980 | 3681 | 52.74% | Â | 930,339 | 329,901 | 35.46% |
MXE | Â | 7950 | 4124 | 51.87% | Â | 944,441 | 332,218 | 35.18% |
AFE | Â | 38,481 | 18,452 | 47.95% | Â | 3,672,503 | 1,235,971 | 33.65% |
ALE | Â | 45,132 | 21,118 | 46.79% | Â | 4,134,137 | 1,377,293 | 33.32% |
ATSS | Â | 92,545 | 47,260 | 51.07% | Â | 11,645,531 | 4,181,752 | 35.91% |
ATTS | Â | 113,447 | 59,169 | 52.16% | Â | 12,675,728 | 4,528,278 | 35.72% |